We are monitoring the impact of COVID-19 on Preclinical In-vivo Imaging Market Get in touch with us for detailed analysis Know More
Share on

Global Preclinical In-vivo Imaging Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report - By Modality, Reagent & Region – Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 532
Pages: 175

Preclinical In-vivo Imaging Market Size (2022 to 2027)

The size of the global preclinical in-vivo imaging market is forecasted to grow at a CAGR of 5.76% from 2022 to 2027. The size of the market is predicted to value USD 999.3 million by 2027 from USD 755.31 million in 2022.

Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Imaging modalities are crucial for researchers to observe changes, either at the organ, tissue, cell, or molecular level, responding to physiological or environmental changes. Non-invasive imaging modalities and in-vivo are essential to study animal models longitudinally. Techniques such as high-frequency micro-ultrasound, magnetic resonance imaging (MRI), and computed tomography (CT) are usually used for anatomical imaging. In contrast, optical imaging (fluorescence and bioluminescence), positron emission tomography (PET), and single-photon emission computed tomography (SPECT) are usually used for molecular visualizations. The preclinical in-vivo imaging industry has experienced myriad technological advancements, market changes due to industry consolidation, and growth in government funding and support for research studies across the globe over the past decade.

Globally, factors such as technological advancements in molecular imaging modalities, growing acceptance of preclinical imaging as a legitimate drug development tool are fuelling the demand for preclinical imaging systems and reagents.

Declining NIH budgets for medical science research studies and the high implementation cost of sophisticated preclinical imaging systems restrict the growth of the global preclinical imaging market.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2027

Base Year

2021

Forecast Period

2022 to 2027

Segments Covered

By Modality, Reagent & Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Aspect ImagingBiospace Lab S.A.Bruker CorporationLI-COR BiosciencesMediso Ltd., MILabs B.V., MR Solutions Ltd, PerkinElmer, Inc., TriFoil Imaging and FUJIFILM VisualSonics, Inc.

 

This research report on the global preclinical in-vivo imaging market has been segmented and sub-segmented based on the modality, reagent, and region.

Preclinical In-vivo Imaging Market - By Modality:                

  • Optical imaging      
    • Bioluminescence/fluorescence imaging systems
    • Standalone fluorescence imaging systems
    • Optical + X-ray/optical + CT imaging systems
  • Nuclear imaging    
    • Micro-PET systems (standalone PET, PET/CT, and PET/MRI)
    • Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI)
    • Tri-modality (PET/SPECT/CT) imaging systems
  • Micro-MRI               
  • Micro-CT  
  • Micro-ultrasound 
  • Photoacoustic        
  • Magnetic particle imaging systems         

Based on modality, the segment of Micro-ultrasound is anticipated to grow with the fastest CAGR. It would be a significant contributor to the global market for preclinical In-vivo imaging. Micro-ultrasound is a smaller ultrasound version with a wider variety of applications, particularly in small animal model research. Some smaller versions of imaging methods improve the techniques ' efficacy. These often decrease the number of animals required for a specific study.      

Preclinical In-vivo Imaging Market - By Reagent:             

  • Optical imaging reagents   
    • Bioluminescent reagents
    • Fluorescent imaging reagents
  • Nuclear imaging reagents 
    • Preclinical PET tracers
    • Preclinical SPECT probes
  • MRI contrast agents            
  • Ultrasound contrast agents             
  • CT contrast agents              

Based on the reagent, the Ultrasound Contrast agents segment is anticipated to dominate the global market owing to their increased application in multiple imaging methods. 

Preclinical In-vivo Imaging Market – By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Regionally, North America holds the largest share of the global preclinical imaging market, followed by Europe. North America dominates the global market given the rapid adoption by end-users of several types of modalities, technological advancement, increased prevalence of chronic diseases like cancer, cardiovascular disease, and many others.

Factors including rising R&D activities by big pharma and biotech companies in developing nations and increased government funding for the pharmaceutical industry's development are stimulating the growth of the preclinical imaging market in the Asia-Pacific region.

KEY MARKET PLAYERS:

Companies like Aspect Imaging, Biospace Lab S.A., Bruker Corporation, LI-COR Biosciences, Mediso Ltd., MILabs B.V., MR Solutions Ltd, PerkinElmer, Inc., TriFoil Imaging, and FUJIFILM VisualSonics, Inc. are currently playing a leading role in the global preclinical in-vivo imaging market.

RECENT MARKET HAPPENINGS:

  • Aspect Imaging, one of the market players in designing and developing compact magnetic resonance systems for preclinical, medical, and industrial applications, unveiled in September 2017 that Quantum Analytics will be its exclusive U.S. distributor for the Industrial product portfolio of Aspect Imaging.
  • In mid-2019, Kawasaki Medical University, the research center for state-of-the-art medical science and services in Yokohama, acquired an ultra-high-resolution E-Class U-SPECT6/CT system for preclinical imaging and installed the first MILabs E-Class U-SPECT6/CT system in Japan.

THIS REPORT COMES WITH:

  • Current and future Preclinical In-vivo Imaging Market outlook in the developed and emerging markets
  • Analyzing various perspectives of the market with the help of Porter’s five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3-month analyst support, along with the Market Estimate sheet (in excel)

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Modality                

                                5.1.1 Optical imaging      

                                                5.1.1.1 Bioluminescence/fluorescence imaging systems

                                                5.1.1.2 Standalone fluorescence imaging systems

                                                5.1.1.3 Optical + X-ray/optical + CT imaging systems

                                5.1.2 Nuclear imaging    

                                                5.1.2.1 Micro-PET systems (standalone PET, PET/CT, and PET/MRI)

                                                5.1.2.2 Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI)

                                                5.1.2.3 Tri-modality (PET/SPECT/CT) imaging systems

                                5.1.3 Micro-MRI               

                                5.1.4 Micro-CT  

                                5.1.5 Micro-ultrasound 

                                5.1.6 Photoacoustic        

                                5.1.7 Magnetic particle imaging systems               

                5.2 By Reagent                 

                                5.2.1 Optical imaging reagents   

                                                5.2.1.1 Bioluminescent reagents

                                                5.2.1.2 Fluorescent imaging reagents

                                5.2.2 Nuclear imaging reagents 

                                                5.2.2.1 Preclinical PET tracers

                                                5.2.2.2 Preclinical SPECT probes

                                5.2.3 MRI contrast agents            

                                5.2.4 Ultrasound contrast agents             

                                5.2.5 CT contrast agents               

6. Geographical Analysis                                              

                6.1 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.2 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.3 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 South Korea           

                6.4 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Mexico     

                                6.4.4 Rest of Latin America          

                6.5 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Aspect Imaging                         

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Biospace Lab S.A.                     

                8.3 Bruker Corporation                 

                8.4 LI-COR Biosciences                  

                8.5 Mediso Ltd.                

                8.6 MILabs B.V.                

                8.7 MR Solutions Ltd                      

                8.8 PerkinElmer               

                8.9 TriFoil Imaging                           

                8.10 FUJIFILM VisualSonics, Inc.                                

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Global Preclinical in-vivo imaging Market, By Region, From 2022 - 2027 (USD Billion)
  2. Global Preclinical in-vivo imaging Market, By Modality, From 2022 - 2027 (USD Billion)
  3. Global Preclinical Optical imaging Market, By Region, From 2022 - 2027 (USD Billion)
  4. Global Preclinical Bioluminescence/fluorescence imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  5. Global Preclinical Standalone fluorescence imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  6. Global Preclinical Optical + X-ray/optical + CT imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  7. Global Preclinical Nuclear imaging Market, By Region, From 2022 - 2027 (USD Billion)
  8. Global Preclinical Micro-PET systems (standalone PET, PET/CT, and PET/MRI) Market, By Region, From 2022 - 2027 (USD Billion)
  9. Global Preclinical Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) Market, By Region, From 2022 - 2027 (USD Billion)
  10. Global Preclinical Tri-modality (PET/SPECT/CT) imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  11. Global Preclinical Micro-MRI Market, By Region, From 2022 - 2027 (USD Billion)
  12. Global Preclinical Micro-CT Market, By Region, From 2022 - 2027 (USD Billion)
  13. Global Preclinical Micro-ultrasound Market, By Region, From 2022 - 2027 (USD Billion)
  14. Global Preclinical Photoacoustic Market, By Region, From 2022 - 2027 (USD Billion)
  15. Global Preclinical Magnetic particle imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  16. Global Preclinical in-vivo imaging Market, By Reagent, From 2022 - 2027 (USD Billion)
  17. Global Preclinical Optical imaging reagents Market, By Region, From 2022 - 2027 (USD Billion)
  18. Global Preclinical Bioluminescent reagents Market, By Region, From 2022 - 2027 (USD Billion)
  19. Global Preclinical Fluorescent imaging reagents Market, By Region, From 2022 - 2027 (USD Billion)
  20. Global Preclinical Nuclear imaging reagents Market, By Region, From 2022 - 2027 (USD Billion)
  21. Global Preclinical PET tracers Market, By Region, From 2022 - 2027 (USD Billion)
  22. Global Preclinical SPECT probes Market, By Region, From 2022 - 2027 (USD Billion)
  23. Global Preclinical MRI contrast agents Market, By Region, From 2022 - 2027 (USD Billion)
  24. Global Preclinical Ultrasound contrast agents Market, By Region, From 2022 - 2027 (USD Billion)
  25. Global Preclinical CT contrast agents Market, By Region, From 2022 - 2027 (USD Billion)
  26. North America Preclinical in-vivo imaging Market, By Region, From 2022 - 2027 (USD Billion)
  27. North America Preclinical in-vivo imaging Market, By Modality, From 2022 - 2027 (USD Billion)
  28. North America Preclinical Optical imaging Market, By Region, From 2022 - 2027 (USD Billion)
  29. North America Preclinical Bioluminescence/fluorescence imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  30. North America Preclinical Standalone fluorescence imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  31. North America Preclinical Optical + X-ray/optical + CT imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  32. North America Preclinical Nuclear imaging Market, By Region, From 2022 - 2027 (USD Billion)
  33. North America Preclinical Micro-PET systems (standalone PET, PET/CT, and PET/MRI) Market, By Region, From 2022 - 2027 (USD Billion)
  34. North America Preclinical Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) Market, By Region, From 2022 - 2027 (USD Billion)
  35. North America Preclinical Tri-modality (PET/SPECT/CT) imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  36. North America Preclinical Micro-MRI Market, By Region, From 2022 - 2027 (USD Billion)
  37. North America Preclinical Micro-CT Market, By Region, From 2022 - 2027 (USD Billion)
  38. North America Preclinical Micro-ultrasound Market, By Region, From 2022 - 2027 (USD Billion)
  39. North America Preclinical Photoacoustic Market, By Region, From 2022 - 2027 (USD Billion)
  40. North America Preclinical Magnetic particle imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  41. North America Preclinical in-vivo imaging Market, By Reagent, From 2022 - 2027 (USD Billion)
  42. North America Preclinical Optical imaging reagents Market, By Region, From 2022 - 2027 (USD Billion)
  43. North America Preclinical Bioluminescent reagents Market, By Region, From 2022 - 2027 (USD Billion)
  44. North America Preclinical Fluorescent imaging reagents Market, By Region, From 2022 - 2027 (USD Billion)
  45. North America Preclinical Nuclear imaging reagents Market, By Region, From 2022 - 2027 (USD Billion)
  46. North America Preclinical PET tracers Market, By Region, From 2022 - 2027 (USD Billion)
  47. North America Preclinical SPECT probes Market, By Region, From 2022 - 2027 (USD Billion)
  48. North America Preclinical MRI contrast agents Market, By Region, From 2022 - 2027 (USD Billion)
  49. North America Preclinical Ultrasound contrast agents Market, By Region, From 2022 - 2027 (USD Billion)
  50. North America Preclinical CT contrast agents Market, By Region, From 2022 - 2027 (USD Billion)
  51. United States Preclinical in-vivo imaging Market, By Modality, From 2022 - 2027 (USD Billion)
  52. United States Preclinical in-vivo imaging Market, By Reagent, From 2022 - 2027 (USD Billion)
  53. United States Preclinical Optical Imaging Market, By Optical imaging, From 2022 - 2027 (USD Billion)
  54. United States Preclinical Nuclear Imaging Market, By Preclinical Nuclear imaging, From 2022 - 2027 (USD Billion)
  55. United States Preclinical Optical imaging reagents Market, By Optical imaging reagents, From 2022 - 2027 (USD Billion)
  56. United States Preclinical Nuclear imaging reagents Market, By Nuclear imaging reagents, From 2022 - 2027 (USD Billion)
  57. Canada Preclinical in-vivo imaging Market, By Modality, From 2022 - 2027 (USD Billion)
  58. Canada Preclinical in-vivo imaging Market, By Reagent, From 2022 - 2027 (USD Billion)
  59. Canada Preclinical Optical Imaging Market, By Optical imaging, From 2022 - 2027 (USD Billion)
  60. Canada Preclinical Nuclear Imaging Market, By Preclinical Nuclear imaging, From 2022 - 2027 (USD Billion)
  61. Canada Preclinical Optical imaging reagents Market, By Optical imaging reagents, From 2022 - 2027 (USD Billion)
  62. Canada Preclinical Nuclear imaging reagents Market, By Nuclear imaging reagents, From 2022 - 2027 (USD Billion)
  63. Europe Preclinical in-vivo imaging Market, By Region, From 2022 - 2027 (USD Billion)
  64. Europe Preclinical in-vivo imaging Market, By Modality, From 2022 - 2027 (USD Billion)
  65. Europe Preclinical Optical imaging Market, By Region, From 2022 - 2027 (USD Billion)
  66. Europe Preclinical Bioluminescence/fluorescence imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  67. Europe Preclinical Standalone fluorescence imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  68. Europe Preclinical Optical + X-ray/optical + CT imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  69. Europe Preclinical Nuclear imaging Market, By Region, From 2022 - 2027 (USD Billion)
  70. Europe Preclinical Micro-PET systems (standalone PET, PET/CT, and PET/MRI) Market, By Region, From 2022 - 2027 (USD Billion)
  71. Europe Preclinical Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) Market, By Region, From 2022 - 2027 (USD Billion)
  72. Europe Preclinical Tri-modality (PET/SPECT/CT) imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  73. Europe Preclinical Micro-MRI Market, By Region, From 2022 - 2027 (USD Billion)
  74. Europe Preclinical Micro-CT Market, By Region, From 2022 - 2027 (USD Billion)
  75. Europe Preclinical Micro-ultrasound Market, By Region, From 2022 - 2027 (USD Billion)
  76. Europe Preclinical Photoacoustic Market, By Region, From 2022 - 2027 (USD Billion)
  77. Europe Preclinical Magnetic particle imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  78. Europe Preclinical in-vivo imaging Market, By Reagent, From 2022 - 2027 (USD Billion)
  79. Europe Preclinical Optical imaging reagents Market, By Region, From 2022 - 2027 (USD Billion)
  80. Europe Preclinical Bioluminescent reagents Market, By Region, From 2022 - 2027 (USD Billion)
  81. Europe Preclinical Fluorescent imaging reagents Market, By Region, From 2022 - 2027 (USD Billion)
  82. Europe Preclinical Nuclear imaging reagents Market, By Region, From 2022 - 2027 (USD Billion)
  83. Europe Preclinical PET tracers Market, By Region, From 2022 - 2027 (USD Billion)
  84. Europe Preclinical SPECT probes Market, By Region, From 2022 - 2027 (USD Billion)
  85. Europe Preclinical MRI contrast agents Market, By Region, From 2022 - 2027 (USD Billion)
  86. Europe Preclinical Ultrasound contrast agents Market, By Region, From 2022 - 2027 (USD Billion)
  87. Europe Preclinical CT contrast agents Market, By Region, From 2022 - 2027 (USD Billion)
  88. U.K Preclinical in-vivo imaging Market, By Modality, From 2022 - 2027 (USD Billion)
  89. U.K Preclinical Optical Imaging Market, By Optical imaging, From 2022 - 2027 (USD Billion)
  90. U.K Preclinical Nuclear Imaging Market, By Preclinical Nuclear imaging, From 2022 - 2027 (USD Billion)
  91. U.K Preclinical in-vivo imaging Market, By Reagent, From 2022 - 2027 (USD Billion)
  92. U.K Preclinical Optical imaging reagents Market, By Optical imaging reagents, From 2022 - 2027 (USD Billion)
  93. U.K Preclinical Nuclear imaging reagents Market, By Nuclear imaging reagents, From 2022 - 2027 (USD Billion)
  94. Spain Preclinical in-vivo imaging Market, By Modality, From 2022 - 2027 (USD Billion)
  95. Spain Preclinical Optical Imaging Market, By Optical imaging, From 2022 - 2027 (USD Billion)
  96. Spain Preclinical Nuclear Imaging Market, By Preclinical Nuclear imaging, From 2022 - 2027 (USD Billion)
  97. Spain Preclinical in-vivo imaging Market, By Reagent, From 2022 - 2027 (USD Billion)
  98. Spain Preclinical Optical imaging reagents Market, By Optical imaging reagents, From 2022 - 2027 (USD Billion)
  99. Spain Preclinical Nuclear imaging reagents Market, By Nuclear imaging reagents, From 2022 - 2027 (USD Billion)
  100. Germany Preclinical in-vivo imaging Market, By Modality, From 2022 - 2027 (USD Billion)
  101. Germany Preclinical Optical Imaging Market, By Optical imaging, From 2022 - 2027 (USD Billion)
  102. Germany Preclinical Nuclear Imaging Market, By Preclinical Nuclear imaging, From 2022 - 2027 (USD Billion)
  103. Germany Preclinical in-vivo imaging Market, By Reagent, From 2022 - 2027 (USD Billion)
  104. Germany Preclinical Optical imaging reagents Market, By Optical imaging reagents, From 2022 - 2027 (USD Billion)
  105. Germany Preclinical Nuclear imaging reagents Market, By Nuclear imaging reagents, From 2022 - 2027 (USD Billion)
  106. Italy Preclinical in-vivo imaging Market, By Modality, From 2022 - 2027 (USD Billion)
  107. Italy Preclinical Optical Imaging Market, By Optical imaging, From 2022 - 2027 (USD Billion)
  108. Italy Preclinical Nuclear Imaging Market, By Preclinical Nuclear imaging, From 2022 - 2027 (USD Billion)
  109. Italy Preclinical in-vivo imaging Market, By Reagent, From 2022 - 2027 (USD Billion)
  110. Italy Preclinical Optical imaging reagents Market, By Optical imaging reagents, From 2022 - 2027 (USD Billion)
  111. Italy Preclinical Nuclear imaging reagents Market, By Nuclear imaging reagents, From 2022 - 2027 (USD Billion)
  112. France Preclinical in-vivo imaging Market, By Modality, From 2022 - 2027 (USD Billion)
  113. France Preclinical Optical Imaging Market, By Optical imaging, From 2022 - 2027 (USD Billion)
  114. France Preclinical Nuclear Imaging Market, By Preclinical Nuclear imaging, From 2022 - 2027 (USD Billion)
  115. France Preclinical in-vivo imaging Market, By Reagent, From 2022 - 2027 (USD Billion)
  116. France Preclinical Optical imaging reagents Market, By Optical imaging reagents, From 2022 - 2027 (USD Billion)
  117. France Preclinical Nuclear imaging reagents Market, By Nuclear imaging reagents, From 2022 - 2027 (USD Billion)
  118. Asia-Pacific Preclinical in-vivo imaging Market, By Region, From 2022 - 2027 (USD Billion)
  119. Asia-Pacific Preclinical in-vivo imaging Market, By Modality, From 2022 - 2027 (USD Billion)
  120. Asia-Pacific Preclinical Optical imaging Market, By Region, From 2022 - 2027 (USD Billion)
  121. Asia-Pacific Preclinical Bioluminescence/fluorescence imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  122. Asia-Pacific Preclinical Standalone fluorescence imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  123. Asia-Pacific Preclinical Optical + X-ray/optical + CT imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  124. Asia-Pacific Preclinical Nuclear imaging Market, By Region, From 2022 - 2027 (USD Billion)
  125. Asia-Pacific Preclinical Micro-PET systems (standalone PET, PET/CT, and PET/MRI) Market, By Region, From 2022 - 2027 (USD Billion)
  126. Asia-Pacific Preclinical Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) Market, By Region, From 2022 - 2027 (USD Billion)
  127. Asia-Pacific Preclinical Tri-modality (PET/SPECT/CT) imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  128. Asia-Pacific Preclinical Micro-MRI Market, By Region, From 2022 - 2027 (USD Billion)
  129. Asia-Pacific Preclinical Micro-CT Market, By Region, From 2022 - 2027 (USD Billion)
  130. Asia-Pacific Preclinical Micro-ultrasound Market, By Region, From 2022 - 2027 (USD Billion)
  131. Asia-Pacific Preclinical Photoacoustic Market, By Region, From 2022 - 2027 (USD Billion)
  132. Asia-Pacific Preclinical Magnetic particle imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  133. Asia-Pacific Preclinical in-vivo imaging Market, By Reagent, From 2022 - 2027 (USD Billion)
  134. Asia-Pacific Preclinical Optical imaging reagents Market, By Region, From 2022 - 2027 (USD Billion)
  135. Asia-Pacific Preclinical Bioluminescent reagents Market, By Region, From 2022 - 2027 (USD Billion)
  136. Asia-Pacific Preclinical Fluorescent imaging reagents Market, By Region, From 2022 - 2027 (USD Billion)
  137. Asia-Pacific Preclinical Nuclear imaging reagents Market, By Region, From 2022 - 2027 (USD Billion)
  138. Asia-Pacific Preclinical PET tracers Market, By Region, From 2022 - 2027 (USD Billion)
  139. Asia-Pacific Preclinical SPECT probes Market, By Region, From 2022 - 2027 (USD Billion)
  140. Asia-Pacific Preclinical MRI contrast agents Market, By Region, From 2022 - 2027 (USD Billion)
  141. Asia-Pacific Preclinical Ultrasound contrast agents Market, By Region, From 2022 - 2027 (USD Billion)
  142. Asia-Pacific Preclinical CT contrast agents Market, By Region, From 2022 - 2027 (USD Billion)
  143. China Preclinical in-vivo imaging Market, By Modality, From 2022 - 2027 (USD Billion)
  144. China Preclinical Optical Imaging Market, By Optical imaging, From 2022 - 2027 (USD Billion)
  145. China Preclinical Nuclear Imaging Market, By Preclinical Nuclear imaging, From 2022 - 2027 (USD Billion)
  146. China Preclinical in-vivo imaging Market, By Reagent, From 2022 - 2027 (USD Billion)
  147. China Preclinical Optical imaging reagents Market, By Optical imaging reagents, From 2022 - 2027 (USD Billion)
  148. China Preclinical Nuclear imaging reagents Market, By Nuclear imaging reagents, From 2022 - 2027 (USD Billion)
  149. India Preclinical in-vivo imaging Market, By Modality, From 2022 - 2027 (USD Billion)
  150. India Preclinical Optical Imaging Market, By Optical imaging, From 2022 - 2027 (USD Billion)
  151. India Preclinical Nuclear Imaging Market, By Preclinical Nuclear imaging, From 2022 - 2027 (USD Billion)
  152. India Preclinical in-vivo imaging Market, By Reagent, From 2022 - 2027 (USD Billion)
  153. India Preclinical Optical imaging reagents Market, By Optical imaging reagents, From 2022 - 2027 (USD Billion)
  154. India Preclinical Nuclear imaging reagents Market, By Nuclear imaging reagents, From 2022 - 2027 (USD Billion)
  155. Japan Preclinical in-vivo imaging Market, By Modality, From 2022 - 2027 (USD Billion)
  156. Japan Preclinical Optical Imaging Market, By Optical imaging, From 2022 - 2027 (USD Billion)
  157. Japan Preclinical Nuclear Imaging Market, By Preclinical Nuclear imaging, From 2022 - 2027 (USD Billion)
  158. Japan Preclinical in-vivo imaging Market, By Reagent, From 2022 - 2027 (USD Billion)
  159. Japan Preclinical Optical imaging reagents Market, By Optical imaging reagents, From 2022 - 2027 (USD Billion)
  160. Japan Preclinical Nuclear imaging reagents Market, By Nuclear imaging reagents, From 2022 - 2027 (USD Billion)
  161. South Korea Preclinical in-vivo imaging Market, By Modality, From 2022 - 2027 (USD Billion)
  162. South Korea Preclinical Optical Imaging Market, By Optical imaging, From 2022 - 2027 (USD Billion)
  163. South Korea Preclinical Nuclear Imaging Market, By Preclinical Nuclear imaging, From 2022 - 2027 (USD Billion)
  164. South Korea Preclinical in-vivo imaging Market, By Reagent, From 2022 - 2027 (USD Billion)
  165. South Korea Preclinical Optical imaging reagents Market, By Optical imaging reagents, From 2022 - 2027 (USD Billion)
  166. South Korea Preclinical Nuclear imaging reagents Market, By Nuclear imaging reagents, From 2022 - 2027 (USD Billion)
  167. Australia Preclinical in-vivo imaging Market, By Modality, From 2022 - 2027 (USD Billion)
  168. Australia Preclinical Optical Imaging Market, By Optical imaging, From 2022 - 2027 (USD Billion)
  169. Australia Preclinical Nuclear Imaging Market, By Preclinical Nuclear imaging, From 2022 - 2027 (USD Billion)
  170. Australia Preclinical in-vivo imaging Market, By Reagent, From 2022 - 2027 (USD Billion)
  171. Australia Preclinical Optical imaging reagents Market, By Optical imaging reagents, From 2022 - 2027 (USD Billion)
  172. Australia Preclinical Nuclear imaging reagents Market, By Nuclear imaging reagents, From 2022 - 2027 (USD Billion)
  173. Latin America Preclinical in-vivo imaging Market, By Region, From 2022 - 2027 (USD Billion)
  174. Latin America Preclinical in-vivo imaging Market, By Modality, From 2022 - 2027 (USD Billion)
  175. Latin America Preclinical Optical imaging Market, By Region, From 2022 - 2027 (USD Billion)
  176. Latin America Preclinical Bioluminescence/fluorescence imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  177. Latin America Preclinical Standalone fluorescence imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  178. Latin America Preclinical Optical + X-ray/optical + CT imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  179. Latin America Preclinical Nuclear imaging Market, By Region, From 2022 - 2027 (USD Billion)
  180. Latin America Preclinical Micro-PET systems (standalone PET, PET/CT, and PET/MRI) Market, By Region, From 2022 - 2027 (USD Billion)
  181. Latin America Preclinical Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) Market, By Region, From 2022 - 2027 (USD Billion)
  182. Latin America Preclinical Tri-modality (PET/SPECT/CT) imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  183. Latin America Preclinical Micro-MRI Market, By Region, From 2022 - 2027 (USD Billion)
  184. Latin America Preclinical Micro-CT Market, By Region, From 2022 - 2027 (USD Billion)
  185. Latin America Preclinical Micro-ultrasound Market, By Region, From 2022 - 2027 (USD Billion)
  186. Latin America Preclinical Photoacoustic Market, By Region, From 2022 - 2027 (USD Billion)
  187. Latin America Preclinical Magnetic particle imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  188. Latin America Preclinical in-vivo imaging Market, By Reagent, From 2022 - 2027 (USD Billion)
  189. Latin America Preclinical Optical imaging reagents Market, By Region, From 2022 - 2027 (USD Billion)
  190. Latin America Preclinical Bioluminescent reagents Market, By Region, From 2022 - 2027 (USD Billion)
  191. Latin America Preclinical Fluorescent imaging reagents Market, By Region, From 2022 - 2027 (USD Billion)
  192. Latin America Preclinical Nuclear imaging reagents Market, By Region, From 2022 - 2027 (USD Billion)
  193. Latin America Preclinical PET tracers Market, By Region, From 2022 - 2027 (USD Billion)
  194. Latin America Preclinical SPECT probes Market, By Region, From 2022 - 2027 (USD Billion)
  195. Latin America Preclinical MRI contrast agents Market, By Region, From 2022 - 2027 (USD Billion)
  196. Latin America Preclinical Ultrasound contrast agents Market, By Region, From 2022 - 2027 (USD Billion)
  197. Latin America Preclinical CT contrast agents Market, By Region, From 2022 - 2027 (USD Billion)
  198. Brazil Preclinical in-vivo imaging Market, By Modality, From 2022 - 2027 (USD Billion)
  199. Brazil Preclinical Optical Imaging Market, By Optical imaging, From 2022 - 2027 (USD Billion)
  200. Brazil Preclinical Nuclear Imaging Market, By Preclinical Nuclear imaging, From 2022 - 2027 (USD Billion)
  201. Brazil Preclinical in-vivo imaging Market, By Reagent, From 2022 - 2027 (USD Billion)
  202. Brazil Preclinical Optical imaging reagents Market, By Optical imaging reagents, From 2022 - 2027 (USD Billion)
  203. Brazil Preclinical Nuclear imaging reagents Market, By Nuclear imaging reagents, From 2022 - 2027 (USD Billion)
  204. Argentina Preclinical in-vivo imaging Market, By Modality, From 2022 - 2027 (USD Billion)
  205. Argentina Preclinical Optical Imaging Market, By Optical imaging, From 2022 - 2027 (USD Billion)
  206. Argentina Preclinical Nuclear Imaging Market, By Preclinical Nuclear imaging, From 2022 - 2027 (USD Billion)
  207. Argentina Preclinical in-vivo imaging Market, By Reagent, From 2022 - 2027 (USD Billion)
  208. Argentina Preclinical Optical imaging reagents Market, By Optical imaging reagents, From 2022 - 2027 (USD Billion)
  209. Argentina Preclinical Nuclear imaging reagents Market, By Nuclear imaging reagents, From 2022 - 2027 (USD Billion)
  210. Mexico Preclinical in-vivo imaging Market, By Modality, From 2022 - 2027 (USD Billion)
  211. Mexico Preclinical Optical Imaging Market, By Optical imaging, From 2022 - 2027 (USD Billion)
  212. Mexico Preclinical Nuclear Imaging Market, By Preclinical Nuclear imaging, From 2022 - 2027 (USD Billion)
  213. Mexico Preclinical in-vivo imaging Market, By Reagent, From 2022 - 2027 (USD Billion)
  214. Mexico Preclinical Optical imaging reagents Market, By Optical imaging reagents, From 2022 - 2027 (USD Billion)
  215. Mexico Preclinical Nuclear imaging reagents Market, By Nuclear imaging reagents, From 2022 - 2027 (USD Billion)
  216. Middle East & Africa Preclinical in-vivo imaging Market, By Region, From 2022 - 2027 (USD Billion)
  217. Middle East & Africa Preclinical in-vivo imaging Market, By Modality, From 2022 - 2027 (USD Billion)
  218. Middle East & Africa Preclinical Optical imaging Market, By Region, From 2022 - 2027 (USD Billion)
  219. Middle East & Africa Preclinical Bioluminescence/fluorescence imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  220. Middle East & Africa Preclinical Standalone fluorescence imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  221. Middle East & Africa Preclinical Optical + X-ray/optical + CT imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  222. Middle East & Africa Preclinical Nuclear imaging Market, By Region, From 2022 - 2027 (USD Billion)
  223. Middle East & Africa Preclinical Micro-PET systems (standalone PET, PET/CT, and PET/MRI) Market, By Region, From 2022 - 2027 (USD Billion)
  224. Middle East & Africa Preclinical Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) Market, By Region, From 2022 - 2027 (USD Billion)
  225. Middle East & Africa Preclinical Tri-modality (PET/SPECT/CT) imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  226. Middle East & Africa Preclinical Micro-MRI Market, By Region, From 2022 - 2027 (USD Billion)
  227. Middle East & Africa Preclinical Micro-CT Market, By Region, From 2022 - 2027 (USD Billion)
  228. Middle East & Africa Preclinical Micro-ultrasound Market, By Region, From 2022 - 2027 (USD Billion)
  229. Middle East & Africa Preclinical Photoacoustic Market, By Region, From 2022 - 2027 (USD Billion)
  230. Middle East & Africa Preclinical Magnetic particle imaging systems Market, By Region, From 2022 - 2027 (USD Billion)
  231. Middle East & Africa Preclinical in-vivo imaging Market, By Reagent, From 2022 - 2027 (USD Billion)
  232. Middle East & Africa Preclinical Optical imaging reagents Market, By Region, From 2022 - 2027 (USD Billion)
  233. Middle East & Africa Preclinical Bioluminescent reagents Market, By Region, From 2022 - 2027 (USD Billion)
  234. Middle East & Africa Preclinical Fluorescent imaging reagents Market, By Region, From 2022 - 2027 (USD Billion)
  235. Middle East & Africa Preclinical Nuclear imaging reagents Market, By Region, From 2022 - 2027 (USD Billion)
  236. Middle East & Africa Preclinical PET tracers Market, By Region, From 2022 - 2027 (USD Billion)
  237. Middle East & Africa Preclinical SPECT probes Market, By Region, From 2022 - 2027 (USD Billion)
  238. Middle East & Africa Preclinical MRI contrast agents Market, By Region, From 2022 - 2027 (USD Billion)
  239. Middle East & Africa Preclinical Ultrasound contrast agents Market, By Region, From 2022 - 2027 (USD Billion)
  240. Middle East & Africa Preclinical CT contrast agents Market, By Region, From 2022 - 2027 (USD Billion)
  241. Middle East Preclinical in-vivo imaging Market, By Modality, From 2022 - 2027 (USD Billion)
  242. Middle East Preclinical Optical Imaging Market, By Optical imaging, From 2022 - 2027 (USD Billion)
  243. Middle East Preclinical Nuclear Imaging Market, By Preclinical Nuclear imaging, From 2022 - 2027 (USD Billion)
  244. Middle East Preclinical in-vivo imaging Market, By Reagent, From 2022 - 2027 (USD Billion)
  245. Middle East Preclinical Optical imaging reagents Market, By Optical imaging reagents, From 2022 - 2027 (USD Billion)
  246. Middle East Preclinical Nuclear imaging reagents Market, By Nuclear imaging reagents, From 2022 - 2027 (USD Billion)
  247. Africa Preclinical in-vivo imaging Market, By Modality, From 2022 - 2027 (USD Billion)
  248. Africa Preclinical Optical Imaging Market, By Optical imaging, From 2022 - 2027 (USD Billion)
  249. Africa Preclinical Nuclear Imaging Market, By Preclinical Nuclear imaging, From 2022 - 2027 (USD Billion)
  250. Africa Preclinical in-vivo imaging Market, By Reagent, From 2022 - 2027 (USD Billion)
  251. Africa Preclinical Optical imaging reagents Market, By Optical imaging reagents, From 2022 - 2027 (USD Billion)
  252. Africa Preclinical Nuclear imaging reagents Market, By Nuclear imaging reagents, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

4255


pdf excel
$

5060


pdf excel powerbi
$

7360


excel
$

2500

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 4255

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample